Skip to main content
Mosaic Biodata
The technical comparison

Whole-genome sequencing vs SNP arrays.

Every consumer DNA test uses one of these two technologies. They're not the same: not in depth, not in coverage, not in what you can do with the data.

  • What the technology reads

    Mosaic WGS (30×)

    All 3 billion base pairs across all chromosomes.

    SNP arrays (consumer chips)

    ~600,000 pre-selected SNP positions (~0.02% of the genome).

  • How positions are selected

    Mosaic WGS (30×)

    No selection — every base is sequenced.

    SNP arrays (consumer chips)

    Manufacturer pre-decides which SNPs the chip captures at chip-design time.

  • Read depth

    Mosaic WGS (30×)

    30× — each position is read ~30 times for variant-call reliability.

    SNP arrays (consumer chips)

    Single-pass hybridization signal; not depth-based.

  • Variant types detected

    Mosaic WGS (30×)

    SNVs, indels, structural variants, copy-number variants, novel/rare variants.

    SNP arrays (consumer chips)

    Pre-selected common SNPs only. Rare/novel variants are invisible.

  • Performance on rare variants

    Mosaic WGS (30×)

    Detected directly from the read data.

    SNP arrays (consumer chips)

    Mostly missed unless the chip happened to include the position.

  • Imputation

    Mosaic WGS (30×)

    Not required — direct reads.

    SNP arrays (consumer chips)

    Required to estimate non-chip positions from chip data and reference panels.

  • Reanalysis when science updates

    Mosaic WGS (30×)

    Re-interpret the existing raw genome at no extra sequencing cost.

    SNP arrays (consumer chips)

    Limited to positions the original chip captured.

  • Throughput / cost trade-off

    Mosaic WGS (30×)

    Higher cost per sample. Higher information density.

    SNP arrays (consumer chips)

    Lower cost per sample. Capped information ceiling.

  • Clinical regulatory standard

    Mosaic WGS (30×)

    Run for clinical interpretation in a CLIA-, COLA-, CAP-, and AABB-accredited lab.

    SNP arrays (consumer chips)

    Consumer-grade genotyping; clinical use requires separate validation.

The trade-off, plainly

A SNP chip is a thumbnail. WGS is the full image.

SNP arrays are a brilliant cost-engineering trick: pre-choose ~600K of the most commonly-varied positions in the human genome and read just those, very cheaply. The chip can’t tell you what’s at the other 99.98% of your DNA.

For ancestry estimates and well-studied common-variant traits, the chip is enough. For clinical interpretation that handles rare variants, structural variants, and new science as it lands, you need the read data behind the calls — which is what 30× whole-genome sequencing gives you.

What this difference actually changes

Depth + breadth = variant calls you can act on. SNP-chip data isn’t built for that.

A SNP chip reads roughly 600,000 hand-picked positions out of 3 billion base pairs, at low depth, with significant imputation. That’s enough for ancestry estimates. It is not enough for clinical-grade variant calls in the genes that shape your detox capacity, your methylation cycle, your thyroid conversion, your iron handling, or your caffeine clearance. Whole-genome sequencing at 30× depth changes the question from “what does the chip happen to cover” to “what does your biology actually say.”

The depth question, settled…

Same cheek swab. Different ceiling.